Calcium gluconate

Suppliers

Names

[ CAS No. ]:
299-28-5

[ Name ]:
Calcium gluconate

[Synonym ]:
Calcium gluconate
D-Gluconic acid,calcium salt
D-Gluconsaeure,Calciumgluconat
EINECS 206-075-8
calglucol
calcicol
Calcium bis[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate]
Calcium di(D-gluconate)
dragocal
Gluconic acid, calcium salt, D-
Calcisan
calcipur
CalciuM Gluconate Monohydrate
novocal
D-gluconic acid,calcium-D gluconate
calcium bis(D-gluconate)
D-Gluconic acid, calcium salt (2:1)
Gluconic Acid Calcium Salt Monohydrate
ebucin
kalpren
D-Gluconic acid calcium salt
2,3,4,5,6-Pentahydroxycaproic Acid hemicalcium salt,Gluconic acid hemicalcium salt
CALCIUM D-GLUCONATE
D-Gluconsaeure,Calcium-D-gluconat
Gluconic acid, calcium salt (2:1), D-
glucal
Calciumbis[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoat]
gluconic acid calcium salt
Ca-D-gluconate
Bis[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate] de calcium
MFCD00064209
Calcium bis[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoate] (non-preferred name)
Biocal
Gluconate (Calcium)

Chemical & Physical Properties

[ Boiling Point ]:
673.6ºC at 760 mmHg

[ Melting Point ]:
195°C

[ Molecular Formula ]:
C6H12O7.1/2Ca

[ Molecular Weight ]:
216.20

[ Flash Point ]:
375.2ºC

[ PSA ]:
254.90000

[ Water Solubility ]:
3.3 g/100mL

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
EW2100000
CHEMICAL NAME :
Calcium gluconate
CAS REGISTRY NUMBER :
299-28-5
LAST UPDATED :
199701
DATA ITEMS CITED :
13
MOLECULAR FORMULA :
C12-H22-O14.Ca
MOLECULAR WEIGHT :
430.42
WISWESSER LINE NOTATION :
QVYQYQYQYQ1Q 2 &-CA-

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Human - infant
DOSE/DURATION :
143 mg/kg
TOXIC EFFECTS :
Skin and Appendages - dermatitis, other (after systemic exposure) Nutritional and Gross Metabolic - body temperature increase
REFERENCE :
JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 129,347,1945
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Human - infant
DOSE/DURATION :
10 gm/kg
TOXIC EFFECTS :
Brain and Coverings - meningeal changes Lungs, Thorax, or Respiration - fibrosis, focal (pneumoconiosis) Nutritional and Gross Metabolic - body temperature increase
REFERENCE :
JAMAAP JAMA, Journal of the American Medical Association. (AMA, 535 N. Dearborn St., Chicago, IL 60610) V.1- 1883- Volume(issue)/page/year: 129,347,1945
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 26,144,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
950 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,226,1982
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
10 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
FRPPAO Farmaco, Edizione Pratica. (Casella Postale 227, 27100 Pavia, Italy) V.8-43 1953-88 For publisher information, see FRMCE8 Volume(issue)/page/year: 26,144,1971
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2200 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JDGRAX Journal of Drug Research. (National Organization for Drug Research and Control, POB 29, Cairo, Egypt) V.2- 1969- Volume(issue)/page/year: 15(1-2),121,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
2890 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 45,47,1956
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
950 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 4,492,1962
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
1987 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 47,183,1933
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
1810 mg/kg
TOXIC EFFECTS :
Cardiac - other changes Lungs, Thorax, or Respiration - dyspnea Gastrointestinal - changes in structure or function of salivary glands
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 191,44,1971 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80373 No. of Facilities: 267 (estimated) No. of Industries: 3 No. of Occupations: 11 No. of Employees: 14905 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 80373 No. of Facilities: 565 (estimated) No. of Industries: 3 No. of Occupations: 16 No. of Employees: 29060 (estimated) No. of Female Employees: 23111 (estimated)

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
20/21/22-36/37/38

[ Safety Phrases ]:
S24/25

[ RIDADR ]:
NONH for all modes of transport

[ WGK Germany ]:
1

[ RTECS ]:
EW2100000

[ HS Code ]:
2918160000

Precursor & DownStream

Precursor

DownStream

  • D-(+)-Xylose

Customs

[ HS Code ]: 2918160000

[ Summary ]:
2918160000. gluconic acid, its salts and esters. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Articles

Calcium Chloride in Neonatal Parenteral Nutrition Solutions with and without Added Cysteine: Compatibility Studies Using Laser and Micro-Flow Imaging Methodology.

PLoS ONE 10 , e0136894, (2015)

Previous studies of compatibility of calcium chloride (CaCl2) and phosphates have not included particle counts in the range specified by the United States Pharmacopeia. Micro-flow imaging techniques h...

Dietary calcium deficiency and excess both impact bone development and mesenchymal stem cell lineage priming in neonatal piglets.

J. Nutr. 144(12) , 1935-42, (2014)

Optimizing calcium nutrition to maximize bone accretion during growth to prevent fragility fractures later in life has spurred greater interest in calcium nutrition in neonates.The aim of this study w...

Goshajinkigan, a traditional Japanese medicine, prevents oxaliplatin-induced acute peripheral neuropathy by suppressing functional alteration of TRP channels in rat.

J. Pharmacol. Sci. 125(1) , 91-8, (2014)

The acute peripheral neuropathy induced by oxaliplatin treatment occurs very frequently and is aggravated by exposure to cold. Goshajinkigan (GJG), a traditional Japanese (kampo) medicine, was recentl...


More Articles


Related Compounds

  • Calcium gluconate
  • calcium gluconate
  • calcium gluconate
  • calcium gluconate
  • CALCIUM GLUCONATE USP
  • Calcium gluconate 1-hydrate
  • 2-((2-methyl-6-(1H-pyrazol-1-yl)pyrimidin-4-yl)oxy)-N-(4-sulfamoylphenyl)acetamide
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 4-[5-(Chloromethyl)-1,2,4-oxadiazol-3-YL]benzonitrile
  • 6-Methyl-1,2,3,4-tetrahydro-1,7-naphthyridine
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 4-nitro-N-[(3S)-pyrrolidin-3-yl]benzene-1-sulfonamide
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide